Doctor profile · Federal record
Dr. Jeffrey Gitt, D.O.
Neurology Physician (CMS: Neurology) · Phoenix, AZ
- NPI 1831370741
- Accepts Medicare
- 43 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 9 locations across 1 states.
- Primary practice
-
3805 E Bell RD Ste 5600
Phoenix, AZ 850322190
(833) 696-3349
fax (972) 499-9210 - Mailing address
-
15301 Spectrum Dr Ste 330
Addison, TX 750016462
Arizona — 8 locations
- Additional location
-
2122 E Highland Ave Ste 265
Phoenix, AZ 850164779 - Additional location
-
2918 W Ina RD Ste 100
Tucson, AZ 857412429 - Additional location
-
3800 W Ray RD Ste 21
Chandler, AZ 852265940
(480) 210-8725 - Additional location
-
3805 E Bell RD Ste 2400
Phoenix, AZ 850322181 - Additional location
-
4400 N 32Nd St Ste 150
Phoenix, AZ 850183977
(602) 482-2116 - Additional location
-
5601 W Eugie Ave Ste 211
Glendale, AZ 853041258 - Additional location
-
5605 W Eugie Ave Ste 210
Glendale, AZ 853041275 - Additional location
-
7406 N la Cholla Blvd
Tucson, AZ 857412306
(602) 482-2116
Credentials & registration
- NPI registered
- November 2007 — 19 yrs on file
- Profile last updated
- February 5, 2024
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Arizona #2023
- Medicaid
- AZ #268806
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831370741. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
51,476
Distinct HCPCS
9
Medicare allowed
$1,955,754
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2350 |
Injection, ocrelizumab, 1 mg | 28,800 | 31 | $52 | |
J2323 |
Injection, natalizumab, 1 mg | 22,200 | 13 | $20 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 163 | 41 | $60 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 82 | 49 | $124 | |
96375 |
Injection of additional new drug or substance into vein | 67 | 32 | $15 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 66 | 34 | $27 | |
J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg | 51 | 33 | $5 | |
96372 |
Injection of drug or substance under skin or into muscle | 25 | 15 | $14 | |
J1200 |
Injection, diphenhydramine hcl, up to 50 mg | 22 | 12 | $1 |
In context: peer comparison
Among 50 peers in Phoenix Neurology Physician, average services per provider: 1,116. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$389
Transactions
4
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 4 | $388.97 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
623
Patients
174
Total drug cost
$100,810
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levetiracetam | Generic | 90 | 30 | $4,153 |
| Gabapentin | Generic | 67 | 20 | $1,816 |
| Baclofen | Generic | 58 | 20 | $1,686 |
| Lamotrigine | Generic | 55 | 19 | $1,309 |
| Donepezil Hcl | Generic | 52 | 23 | $545 |
| Memantine Hcl | Generic | 49 | 17 | $1,350 |
| Dalfampridine ER (Dalfampridine) | Brand | 44 | 11 | $15,759 |
| Botox (Onabotulinumtoxina) | Brand | 42 | 18 | $67,959 |
| Carbidopa-Levodopa (Carbidopa/Levodopa) | Brand | 36 | 16 | $2,058 |
| Topiramate | Generic | 31 | 0 | $483 |
Frequently asked questions
What is Dr. Jeffrey Gitt's medical specialty?
Dr. Jeffrey Gitt practices Neurology Physician in Phoenix, AZ.
Where does Dr. Jeffrey Gitt practice?
Dr. Jeffrey Gitt practices at 3805 E Bell RD Ste 5600, Phoenix, AZ 850322190. Office phone: 8336963349.
What is Dr. Jeffrey Gitt's NPI?
Dr. Jeffrey Gitt's National Provider Identifier (NPI) is 1831370741, issued by NPPES.
Does Dr. Jeffrey Gitt accept Medicare assignment?
Yes. Dr. Jeffrey Gitt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jeffrey Gitt commonly perform?
Top Medicare-reported procedures in 2023: Injection, ocrelizumab, 1 mg (HCPCS J2350); Injection, natalizumab, 1 mg (HCPCS J2323); Infusion into a vein for therapy, prevention, or diagnosis (HCPCS 96365). Source: CMS Medicare Physician & Other Practitioners file.